Prognosis Associated with CA19–9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

Prognosis Associated with CA19–9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma

Published:2021-08-20 Issue: Volume:Publish Ahead of Print Page:
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Newhook Timothy E.,Vreeland Timothy J.,Griffin James F.,Tidwell Rebecca S. S.,Prakash Laura R.,Koay Eugene J.,Ludmir Ethan B.,Smaglo Brandon G.,Pant Shubham,Overman Michael,Wolff Robert A.,Ikoma Naruhiko,Maxwell Jessica,Kim Michael P.,Lee Jeffrey E.,Katz Matthew H. G.,Tzeng Ching-Wei D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer;Surgery;2024-10

2. Chemotherapy switch for nonresponse or progression on neoadjuvant chemotherapy for pancreatic adenocarcinoma;Journal of Surgical Oncology;2024-08-19

3. Emerging role of local treatment in the era of advanced systemic treatment in pancreatic cancer with liver metastasis: A systematic review and meta‐analysis;Journal of Hepato-Biliary-Pancreatic Sciences;2024-07-17

4. Comprehensive transcriptomic analysis identifies SLC25A4 as a key predictor of prognosis in osteosarcoma;Frontiers in Genetics;2024-06-18

5. Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy;JAMA Network Open;2024-06-18